The findings point the way to treatment options targeting group 1 metabotropic glutamate receptors. This study is a major step toward the ultimate goal of treating fragile X syndrome (FXS), an ...

Researchers at Weill Cornell Medicine have made promising advances in understanding how to reduce anxiety through specific ...

In their study, published Jan. 28 in Neuron, the researchers examined the effects of experimental drug compounds that ...